We demonstrate that whereas the conjugated A-beta-HSP vaccine promoted a very mild T-cell response in a humanized mouse model of AD carrying the DR-DRB1*1501 allele, the humoral response was sufficient to promote a significant reduction of cerebral amyloid burden as well as of the associated inflammatory response.